Assessing Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients

Status: Recruiting
Location: See location...
Intervention Type: Other, Device
Study Type: Observational
SUMMARY

With modern therapy, the survival rate for pediatric brain tumor patients has significantly improved, with over 70% of patients surviving their disease. However, this progress often comes at the cost of substantial morbidity, with cognitive deficits being the primary obstacle to independent living. Robust predictors of cognitive decline and a comprehensive understanding of the underlying mechanisms of cognitive injury remain elusive. This study will prospectively investigate alterations in brain resting state networks following radiation therapy using functional imaging. The hypothesis is that radiation therapy leads to dose-dependent alterations in functional connectivity in the networks associated with higher level cognition, ultimately leading to cognitive decline.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 8
Maximum Age: 21
Healthy Volunteers: f
View:

• Between 8 and 21 years of age, inclusive

• Newly diagnosed primary brain tumor of any location and any histology that will be treated with proton radiation therapy

• Life expectancy of at least one year

• Able to understand and willing to consent or assent to the research proposed (or that of a legally authorized representative, if applicable), along with consent of legal guardian(s) if applicable

Locations
United States
Missouri
Washington University School of Medicine/Saint Louis Children's Hospital
RECRUITING
St Louis
Contact Information
Primary
Stephanie Perkins, M.D.
sperkins@wustl.edu
314-747-4405
Time Frame
Start Date: 2024-07-10
Estimated Completion Date: 2027-07-31
Participants
Target number of participants: 16
Treatments
Brain tumor patients receiving proton radiation therapy
Patients between 8 and 21 years old (inclusive) with a newly diagnosed primary brain tumor that will be treated with proton radiation therapy
Related Therapeutic Areas
Sponsors
Leads: Washington University School of Medicine
Collaborators: The Foundation for Barnes-Jewish Hospital, United States Department of Defense, Children's Cancer Research Fund

This content was sourced from clinicaltrials.gov